Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  18 (2024)
Volume  17 (2023)
Volume  16 (2022)
Volume  15 (2021)
Volume  14 (2020)
Volume  13 (2019)
Volume  12 (2018)
Volume  11 (2017)
Volume  10 (2016)
Volume  9 (2015)
Volume  8 (2014)
Volume  7 (2013)
Volume  6 (2012)
Volume  5 (2011)
Volume  4 (2010)
Volume  3 (2009)
Volume  2 (2008)
Volume  1 (2007)
Related articles

VOLUME 9 , ISSUE 3 ( July-September, 2015 ) > List of Articles

RESEARCH ARTICLE

Challenges in Sonographic Detection of Fetal Major Structural Abnormalities at the First Trimester Anomaly Scan

Aris Antsaklis, Daniela Paulescu, Stefania Tudorache, Iuliana Ceausu, Liliana Novac, Nicolae Cernea, Dominic Iliescu, Monica Cara

Keywords : Anomaly scan,Early or mid pregnancy,First trimester

Citation Information : Antsaklis A, Paulescu D, Tudorache S, Ceausu I, Novac L, Cernea N, Iliescu D, Cara M. Challenges in Sonographic Detection of Fetal Major Structural Abnormalities at the First Trimester Anomaly Scan. Donald School J Ultrasound Obstet Gynecol 2015; 9 (3):239-259.

DOI: 10.5005/jp-journals-10009-1411

License: CC BY-NC 4.0

Published Online: 01-03-2016

Copyright Statement:  Copyright © 2015; The Author(s).


Abstract

How to cite this article

Iliescu D, Cara M, Tudorache S, Antsaklis P, Ceausu I, Paulescu D, Novac L, Cernea N, Antsaklis A. Challenges in Sonographic Detection of Fetal Major Structural Abnormalities at the First Trimester Anomaly Scan. Donald School J Ultrasound Obstet Gynecol 2015;9(3):239-259.

PDF Share
  1. A model for a new pyramid of prenatal care based on the 11 to 13 weeks’ assessment. Prenat Diagn 2011; 31(1):3-6.
  2. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31(1):7-15.
  3. Prediction of miscarriage and stillbirth at 11–13 weeks and the contribution of chorionic villus sampling. Prenat Diagn 2011;31(1):38-45.
  4. First-trimester serum PAPP-A and fß-hCG concentrations and other maternal characteristics to establish logistic regression- based predictive rules for adverse pregnancy outcome. Prenat Diagn. Prenat Diagn 2011;31(1):50-57.
  5. Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11–13 weeks. Prenat Diagn 2011;31(1):75-83.
  6. Prediction of spontaneous preterm delivery from endocervical length at 11 to 13 weeks. Prenat Diagn 2011; 31(1):84-89.
  7. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 2011;31(1):66-74.
  8. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 2007;11:1-125.
  9. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 2011;31(2):135-141.
  10. Criteria for screening and diagnosis of gestational diabetes mellitus in the first trimester of pregnancy. Fetal Diagn Ther 2011;30(2):108-115.
  11. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks. Fetal Diagn Ther 2011;29(2):148-154.
  12. First-trimester prediction of macrosomia. Fetal Diagn Ther 2011;29(2):139-147.
  13. ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2013;41(1):102-113.
  14. Antenatal care Routine care for the healthy pregnant woman NICE clinical guideline 62 [Internet]. 2008. Available at: http://www.nice.org.uk/nicemedia/pdf/CG062NICEguideline.pdf.
  15. Issues Position on First-Trimester Screening Methods. ACOG NEWS RELEASE [Internet]. 2004 June. Available at: http://www.acog.org/from_home/publications/press_releases/nr06-30-04.cfm.
  16. New recommendations for down syndrome: screening should be offered to all pregnant women; 2006 Dec. Available at: http://www.acog.org/from_home/publications/press_releases/nr01-02-07-1.cfm.
  17. AIUM practice guideline for the performance of obstetric ultrasound examinations [Internet]. 2007 Oct. Available at: http://www.aium.org/resources/guidelines/obstetric.pdf.
  18. Evolving applications of first-trimester ultrasound. OBG Management 2012;24(12):36-45.
  19. Early pregnancy scanning for fetal anomalies—the new standard? Clin Obstet Gynecol 2012; 55(1):199-216.
  20. Routine Obstetric Sonography. J Ultrasound Med 2002;21(7):713-718.
  21. Training in Diagnostic Ultrasound: essentials, principles, and standards. World Health Organ Tech Rep Ser 1998;875:i-46.
  22. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2011;37(1):116-126.
  23. Feasibility of the second-trimester fetal ultrasound examination in an unselected population at 18, 20 or 22 weeks of pregnancy: a randomized trial. Ultrasound Obstet Gynecol 1999;14(2):92-97.
  24. Detection of malformations in chromosomally normal fetuses by routine ultrasound at 12 or 18 weeks of gestation —a randomised controlled trial in 39,572 pregnancies. BJOG 2006;113(6):664-674.
  25. Prenatal detection of heart defects in a non-selected population of 30149 fetuses—detection rates and outcome. Ultrasound Obstet Gynecol 2006;27(3):252-265.
  26. Routine screening for fetal anomalies: expectations. Obstet Gynecol Clin North Am 2004;31(1):35-50.
  27. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol 1999;181(2):446-454.
  28. Perception of information, expectations and experiences among women and their partners attending a second-trimester routine ultrasound scan. Ultrasound Obstet Gynecol 1997;9(2):86-90.
  29. Ultrasound screening for fetal abnormalities. Report of the RCOG Working Party [Internet]. London: The Royal College of Obstetricians and Gynaecologist; 1997. Available at: http://www.febrasgo.org.br/site/wp-content/uploads/2013/10/Ultrasound_Screening-GUIDELINE-ROYAL_COLLEGE.pdf
  30. Screening for fetal anomalies in the 12th week of pregnancy by transvaginal sonography in an unselected population. Prenat Diagn 1997;17(8):753-759.
  31. Comparison of first trimester and second trimester screening for fetal anomalies. Ann NY Acad Sci 1998;847(1):200-209.
  32. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998;11(6):401-406.
  33. Results of routine fetal nuchal translucency measurement at weeks 10–13 in 4233 unselected pregnant women. Prenat Diagn 1998;18(1):29-34.
  34. The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population. Br J Obstet Gynaecol 1999 Sep;106(9):929-936.
  35. First trimester ultrasonographic diagnosis of fetal structural abnormalities in a low risk population. Br J Obstet Gynaecol 1998;105(1):53-57.
  36. Transvaginal sonographic detection of embryonicfetal abnormalities in early pregnancy. Obstet Gynecol 2000;96(3):328-332.
  37. Two-stage ultrasonography in screening for fetal anomalies at 13–14 and 18–22 weeks of gestation. Acta Obstet Gynecol Scand 2004;83:1141-1146.
  38. Ultrasound screening of fetal structural abnormalities at 12 to 14 weeks in Hong Kong. Prenat Diagn 2004;24(2):92-97.
  39. Screening for major structural abnormalities at the 11- to 14-week ultrasound scan. Am J Obstet Gynecol 2006;194(2):393-396.
  40. Detailed screening for fetal anomalies and cardiac defects at the 11–13-week scan. Ultrasound Obstet Gynecol 2006;27(6):613-618.
  41. Detection of fetal structural abnormalities by an 11–14-week ultrasound dating scan in an unselected Swedish population. Acta Obstet Gynecol Scand 2006;85(8):912-915.
  42. Ultrasound screening for fetal major abnormalities at 11–14 weeks. Acta Obstet Gynecol Scand 2007;86(6):666-670.
  43. Comparison of nuchal and detailed morphology ultrasound examinations in early pregnancy for fetal structural abnormality screening: a randomized controlled trial. Ultrasound Obstet Gynecol 2008;31(2):136-146.
  44. Ultrasonographic diagnosis of fetal structural abnormalities in prenatal screening at 11–14 weeks. Diagn Interv Radiol 2009;15(3): 221-225.
  45. 13–14-Week fetal anatomy scan: a 5-year prospective study. Ultrasound Obstet Gynecol 2010;35(3):292-296.
  46. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11–13 weeks. Prenat Diagn 2011;31(1):90-102.
  47. Improved detection rate of structural abnormalities in the first trimester using an extended examination protocol. Ultrasound Obstet Gynecol 2013;42(9):300-309.
  48. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005;192(4):1005-1021.
  49. Diagnostic performance of routine ultrasound screening for fetal abnormalities in an unselected Swedish population in 2000-2005. Ultrasound Obstet Gynecol 2009;34(5):526-533.
  50. Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost effectiveness and women's views. Health Technol Assess 2000; 4(16):1-193.
  51. Qualified and trained sonographers in the US can perform early fetal anatomy scans between 11 and 14 weeks. Am J Obstet Gynecol 2004;191(4):1247-1252.
  52. Fetal heart defects: Potential and pitfalls of first-trimester detection. Seminars in Fetal & Neonatal Med 2013;18(5):251-260.
  53. Assessment of fetal anatomy at the 11–14- week ultrasound examination. Ultrasound Obstet Gynecol 2004;24(7):730-734.
  54. Low-resistance hepatic artery flow in first-trimester fetuses: an ominous sign. Ultrasound Obstet Gynecol 2011;37(4):438-443.
  55. Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol 2007; 109(6):1455-1456.
  56. Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol 2011;117(6):1384-1391.
  57. Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects. Fetal Diagn Ther 2011;29(2):127-134.
  58. From nuchal translucency to intracranial translucency: towards the early detection of spina bifida. Ultrasound Obstet Gynecol 2010;35(2):133-138.
  59. Posterior brain in fetuses with open spina bifida at 11 to 13 weeks. Prenat Diagn 2011;31(1):103-106.
  60. Screening for fetal spina bifida by ultrasound examination in the first trimester of pregnancy using fetal biparietal diameter. Am J Obstet Gynecol 2012;207(4):306.e1-5.
  61. Retronasal triangle: a sonographic landmark for the screening of cleft palate in the first trimester. Ultrasound Obstet Gynecol 2010;35(1):7-13.
  62. First-trimester assessment of the nasal bones using the retronasal triangle view: a 3-dimensional sonographic study. J Ultrasound Med 2010; 29(11):1555-1561.
  63. Absent mandibular gap in the retronasal triangle view: a clue to the diagnosis of micrognathia in the first trimester. Ultrasound Obstet Gynecol 2012;39(2):152-156.
  64. Early prenatal diagnosis of skeletal anomalies. Prenat Diagn 2011;31(1):115-124.
  65. First-trimester detection of structural abnormalities and the role of aneuploidy markers. Ultrasound Obstet Gynecol 2012;39(2):157-163.
  66. First-trimester ultrasound diagnosis of skeletal dysplasia associated with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2007;30(2):221-226.
  67. Fetal nuchal translucency thickness at 10–14 weeks’ gestation and congenital diaphragmatic hernia. Obstet Gynecol 1997;90(6):943-946.
  68. Outcome of First Trimester Fetal Abdominal Cysts: A Cohort Study and Review of the Literature. Ultrasound Obstet Gynecol 2014;43(4):413-419.
  69. Upper abdominal cysts in first trimester fetuses. Ultraschall Med 2012;33(7):E372-373.
  70. Fetal abdominal cysts in the first trimester: prenatal detection and clinical significance. Ultrasound Obstet Gynecol 2008;32(7):860-864.
  71. First trimester two- and four-dimensional cardiac scan—intra-and interobserver agreement, comparison between methods and benefits of color Doppler technique. Ultrasound Obstet Gynecol 2013;42(6):659-668.
  72. Fetal echocardiography at the time of the nuchal translucency scan. Ultrasound Obstet Gynecol 2007;29(3):249-257.
  73. Fetal echocardiography at 11–13 weeks by transabdominal high-frequency ultrasound. Ultrasound Obstet Gynecol 2011;37(3):296-301.
  74. Fetal transabdominal anatomy scanning using standard views at 11 to 14 weeks’ gestation. Am J Obstet Gynecol 2005;192(2):535-542.
  75. Intra-and interoperator reliability of manual and semi-automated measurements of intracranial translucency. Ultrasound Obstet Gynecol 2012;39(2):164-168.
  76. Reliability of the first-trimester cardiac scan by ultrasound-trained obstetricians with high-frequency transabdominal probes in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol. Ultrasound Obstet Gynecol 2010;36(3):272-278.
  77. Reliability of manual and semi-automated measurements of nuchal translucency by experienced operators. Int J Gynaecol Obstet 2013;121(3):240-242.
  78. Intra-and interoperator reliability of manual and semi-automated measurement of fetal nuchal translucency by sonographers with different levels of experience. Ultrasound Obstet Gynecol 2010;36(4):417-422.
  79. Reliability analysis on ductus venosus assessment at 11-14 weeks’ gestation in a high-risk population. Prenat Diagn 2007;27(5):442-446.
  80. Fetal tricuspid valve Doppler at 11-13 weeks and 6 days: reference values and reproducibility. Prenat Diagn 2010;30(8): 790-794.
  81. Reliability of fetal nasal bone length measurement at 11-14 weeks of gestation. BMC Pregnancy Childbirth 2013;13:7.
  82. Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol 2002;20(1):22-29.
  83. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart 2003;89(9): 1071-1073.
  84. Detection rate of early fetal echocardiography and in utero development of congenital heart defects. J Ultrasound Med 2005;25(2):187-196.
  85. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency. Ultrasound Obstet Gynecol 2010;35(3):267-272.
  86. Diagnosis of congenital heart disease by early and second-trimester fetal echocardiography. J Ultrasound Med 2012;31(4):563-568.
  87. Early screening for fetal cardiac anomalies by transvaginal echocardiography in an unselected population: the role of the operator experience. Ultrasound Obstet Gynecol 2000;16(7):614-619.
  88. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001;17(2):106-110.
  89. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies. Heart 2004;90(8):921-926.
  90. The potential of first trimester anomaly scan and first trimester fetal echocardiography as screening procedures in a medium risk population. J Obstet Gynecol Ind 2005;55(3):228-230.
  91. Routine ultrasound examination at 12 or 18 gestational weeks for prenatal detection of major congenital heart malformations? A randomised controlled trial comprising 36 299 fetuses. BJOG 2006;113(6):675-682.
  92. The diagnostic accuracy of the 13-14 weeks scan and nuchal translucency measurement in the early detection of fetal congenital anomalies. KAJOG 2012;1(1):10-14.
  93. ISUOG Practice Guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2013;41(1):102-113.
  94. Echocardiography in early pregnancy: Review of literature. J Ultrasound Med 2003;22(3):271-280.
  95. Early fetal echocardiography: heart biometry and visualization of cardiac structures between 10 and 15 weeks' gestation. J Ultrasound Med 2006;25(2):173-182.
  96. How successful is fetal echocardiographic examination in the first trimester of pregnancy? Ultrasound Obstet Gynecol 2002;20(1):9-13.
  97. Screening performance of first-trimester nuchal translucency for major cardiac defects: A meta-analysis. Am J Obstet Gynecol 2003;189(5):1330-1335.
  98. Cardiac screening examination of the fetus: guidelines for performing the ‘basic’ and ‘extended basic’ cardiac scan. Ultrasound Obstet Gynecol 2006;27(1):107-113.
  99. AIUM practice guideline for the performance of fetal echocardiography. J Ultrasound Med 2011;30(1):127-136.
  100. Routine Use of Color Doppler in Fetal Heart Scanning in a Low-Risk Population. ISRN Obstet Gynecol 2012;2012:496935.
  101. ISUOG statement on the safe use of Doppler in the 11 to 13+6-week fetal ultrasound examination. Ultrasound Obstet Gynecol 2011;37(6):628.
  102. 3D and 4D ultrasound in fetal cardiac scanning: a new look at the fetal heart. Ultrasound Obstet Gynecol 2007;29(1):81-95.
  103. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13+6-week scan. Ultrasound Obstet Gynecol 2005;26(1):22-27.
  104. Ductus Venosus in the First Trimester: Contribution to Screening of Chromosomal, Cardiac Defecxts and Monochorionic Twin Complications. Fetal Diagn Ther 2010;28(2):65-71.
  105. Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome in fetuses with normal nuchal translucency. Ultrasound Obstet Gynecol 2007;30(2):192-196.
  106. First-trimester ductus venosus screening for cardiac defects: a meta-analysis. BJOG 2011;118(12):1438-1445.
  107. Accuracy of the Fetal Echocardiography in the High Risk Pregnancies. Donald School J Ultrasound Obstet Gynecol 2007;1(1):86-95.
  108. The sonographic approach to the detection of fetal cardiac anomalies in early pregnancy. Ultrasound Obstet Gynecol 2002;19(4):360-365.
  109. Prenatal diagnosis of congenital heart disease using four-dimensional spatio-temporal image correlation (STIC) telemedicine via an Internet link: a pilot study. Ultrasound Obstet Gynecol 2005;25(1):25-31.
  110. Spatio-temporal image correlation (STIC): a new tool for the prenatal screening of congenital heart defects. Ultrasound Obstet Gynecol 2003; 22(4):388-394.
  111. Accuracy of four-dimensional spatiotemporal image correlation echocardiography in the prenatal diagnosis of congenital heart defects. Ultrasound Obstet Gynecol 2010;36(4):458-464.
  112. Feasibility and accuracy of fetal echocardiography using four-dimensional spatiotemporal image correlation technology before 16 weeks' gestation. Ultrasound Obstet Gynecol 2009;33(6):645-651.
  113. Performance of Different Scan Protocols of Fetal Echocardiography in the Diagnosis of Fetal Congenital Heart Disease: A Systematic Review and Meta-Analysis. PLoS ONE 2013;8(6):e65484.
  114. A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol 2006;28(1):110-116.
  115. Accuracy and limitation of transabdominal fetal echocardiography at 12 to 15 weeks of gestation in a population at high risk of congenital heart disease. BJOG 2000;107(12):1492-1497.
  116. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005;192(1):89-95.
  117. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001;18(6):610-614.
  118. The nuchal translucency and the fetal heart: a literature review. Prenatal Diagnosis 2009;29(8):739-748.
  119. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005;26(2):154-157.
  120. Increased nuchal translucency in euploid fetuses—what should we be telling the parents? Prenat Diagn 2010;30(2):93-102.
  121. First trimester fetal echocardiography. state of the problem. TMJ 2009;59(2):173-183.
  122. Nuchal translucency and the risk of congenital heart disease. Obstetrics Gynecol 2007;109(2 Pt 1):376-383.
  123. ; Abbas, AL.; Fauston, N.. Robbins and Cotran's Pathologic Basis of Disease. 7th ed. New York: Saunders; 2004. 470 p.
  124. A normal second-trimester ultrasound does not exclude intracranial structural pathology. Ultrasound Obstet Gynecol 2002;20(1):51-56.
  125. Accurate neurosonographic prediction of brain injury in the surviving fetus after the death of a monochorionic cotwin. Ultrasound Obstet Gynecol 2006;27(5):517-521.
  126. Outcome of antenatally diagnosed intracranial hemorrhage: case series and review of the literature. Ultrasound Obstet Gynecol 2003;22(2):121-130.
  127. Sonographic demonstration of brain injury in fetuses with severe red blood cell alloimmunization undergoing intrauterine transfusions. Ultrasound Obstet Gynecol 2004;23(5):428-431.
  128. Fetal spinal anomalies in a first-trimester sonographic screening program for aneuploidy. Prenat Diagn 2011;31(1):107-114.
  129. Detection of fetal structural abnormalities at the 11-14 week ultrasound scan. Prenat Diagn 2002;22(1):1-4.
  130. Presence of the ‘lemon’ sign in fetuses with spina bifida at the 10–14-week scan. Ultrasound Obstet Gynecol 1997;10(6):403-405.
  131. Sonographic diagnosis of spina bifida at 12 weeks: heading towards indirect signs. Ultrasound Obstet Gynecol 2002;19(3):290-292.
  132. Neuroimaging parameters in early open spina bifida detection. Further benefit in first trimester screening? Rom J Morphol Embryol 2011;52(3):809-817.
  133. Cisterna magna width at 11-13 weeks in the detection of posterior fossa anomalies. Ultrasound Obstet Gynecol 2013;41(5):515-520.
  134. Appearance of the fetal posterior fossa at 11 + 3 to 13 + 6 gestational weeks on transabdominal ultrasound examination. Ultrasound Obstet Gynecol 2011;38(6):620-624.
  135. Sonographic examination of the fetal central nervous system: guidelines for performing the ‘basic examination’ and the ‘fetal neurosonogram’. Ultrasound Obstet Gynecol 2007;29(1):109-116.
  136. The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 1998;11(4): 258-261.
  137. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free betahuman chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;31(6):618-624.
  138. Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. Prenat Diagn 2008;28(9):839-844.
  139. First-trimester combined screening for trisomy 21 at 7–14 weeks gestation. Ultrasound Obstet Gynecol 2010;36(4):404-411.
  140. Conclusions regarding epidemiology for obstetric ultrasound. J Ultrasound Med 2008;27(4):637-644.
  141. Medical ultrasound safety. Laurel, Maryland: AIUM; 1999.
  142. Safety Statement, 2000 (reconfirmed 2003). Ultrasound Obstet Gynecol 2003;21(1):100.
  143. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis. Ultrasound Obstet Gynecol 2009;33(5):599-608.
  144. Ultrasound in obstetrics: a review of safety. Eur J Obstet Gynecol Reprod Biol 2002;101(1):15-18.
  145. Ultrasound safety in early pregnancy: reduced energy setting does not compromise obstetric Doppler measurements. Ultrasound Obstet Gynecol 2012;39(4):438-443.
  146. First-trimester diagnosis of cleft lip and palate using three-dimensional ultrasound. Ultrasound Obstet Gynecol 2012;40(1):40-46.
  147. 3D/4D sonography moved prenatal diagnosis of fetal anomalies from the second to the first trimester of pregnancy. J Matern Fetal Neonatal Med 2012; 25(5):433-455.
  148. Fetal anatomic survey using three-dimensional ultrasound in conjunction with first-trimester nuchal translucency screening. Prenat Diagn 2010;30(3):267-273.
  149. Psychological outcome in women undergoing termination of pregnancy for ultrasound-detected fetal anomaly in the first and second trimesters: a pilot study. Ultrasound Obstet Gynecol 2005;25(4):389-392.
  150. Women's opinions and the implications of first versus second-trimester screening for fetal Down's syndrome. Prenat Diagn 1997;17(11):1011-1018.
  151. Transvaginal fetal echocardiography in early pregnancy: normative data. Am J Obstet Gynecol 1991;165(3):688-691.
  152. Early fetal anomaly scanning in a population at increased risk of abnormalities. Ultrasound Obstet Gynecol 2002;19(6):570-574.
  153. Screening for structural fetal anomalies during the nuchal translucency ultrasound examination. Am J Obstet Gynecol 2007;197(2):181.e1-5.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.